enVVeno Medical Corporation (NVNO)

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.59	3.07	1.75	3.62	4.56	54.73
Short-Term Investments	15.89	25.15	41.4	42.79	34.49	-
Cash & Short-Term Investments	18.47	28.21	43.15	46.41	39.04	54.73
Cash Growth	-40.32%	-34.62%	-7.02%	18.87%	-28.66%	486.29%
Prepaid Expenses	0.55	0.61	0.58	0.51	0.39	0.31
Total Current Assets	19.02	28.83	43.73	46.92	39.44	55.04
Property, Plant & Equipment	0.44	0.71	1.19	1.68	2.19	2.61
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.03	0.05
Total Assets	19.49	29.56	44.95	48.64	41.66	57.7

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.18	0.36	1.01	0.43	0.65	0.56
Accrued Expenses	-	1.37	0.73	0.61	0.57	0.73
Current Portion of Leases	0.41	0.39	0.36	0.34	0.31	0.29
Total Current Liabilities	2.59	2.12	2.1	1.37	1.53	1.58
Long-Term Leases	-	0.31	0.7	1.06	1.4	1.72
Total Liabilities	2.59	2.43	2.8	2.44	2.93	3.3

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	200.04	198.46	194.01	176.24	145.25	136.26
Retained Earnings	-183.14	-171.33	-151.86	-130.04	-106.52	-81.85
Total Common Equity	16.9	27.13	42.16	46.2	38.73	54.4
Shareholders' Equity	16.9	27.13	42.16	46.2	38.73	54.4
Total Liabilities & Equity	19.49	29.56	44.95	48.64	41.66	57.7

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.41	0.7	1.06	1.4	1.72	2.01
Net Cash (Debt)	18.06	27.51	42.09	45.01	37.33	52.72
Net Cash Growth	-40.11%	-34.63%	-6.49%	20.58%	-29.20%	523.64%
Net Cash Per Share	27.34	46.71	85.90	128.07	137.93	212.59
Filing Date Shares Outstanding	0.69	0.66	0.5	0.38	0.27	0.27
Total Common Shares Outstanding	0.7	0.66	0.5	0.38	0.27	0.27
Working Capital	16.43	26.7	41.64	45.55	37.91	53.46
Book Value Per Share	24.32	41.36	84.15	121.42	143.11	201.07
Tangible Book Value	16.9	27.13	42.16	46.2	38.73	54.4
Tangible Book Value Per Share	24.32	41.36	84.15	121.42	143.11	201.07
Machinery	-	1.44	1.44	1.4	1.37	0.81
Leasehold Improvements	-	-	-	-	-	0.19

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error